M. Di Iorio

Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project

C. Catalano, A. Cutini, S. Ceccarelli, 2022, Journal of Endocrinological Investigation.

Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project

C. Catalano, A. Cutini, S. Ceccarelli, 2022, Journal of Endocrinological Investigation.

Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project

C. Catalano, A. Cutini, S. Ceccarelli, 2022, Journal of Endocrinological Investigation.

Heart disease mortality during the early pandemic period in the United States.

H. Krumholz, J. Faust, C. Walsh, 2020, medRxiv.

Does cirrhotic cardiomyopathy exist? 50 years of uncertainty

J. Cleland, M. Merli, C. Torromeo, 2013, Clinical Research in Cardiology.

Impact of COVID-19 Pandemic on Cardiac Electronic Device Management and Role of Remote Monitoring

F. Fedele, C. Lavalle, R. Quaglione, 2021, Cardiac Electrophysiology Clinics.

Greater cardiovascular risk reduction with once-daily fixed combination of three antihypertensive agents and statin versus free-drug combination: The ALL-IN-ONE trial.

F. Pelliccia, M. Volterrani, G. Marazzi, 2016, International journal of cardiology.